Form 4: Director Joseph Pellegrino Jr. Acquires LMAT Shares

Sentiment:

Insider Ownership Change


Lemaitre Vascular Director Joseph P. Pellegrino Jr. acquired 20 shares of common stock through the vesting of restricted and performance stock units.

Summary

  • Joseph P. Pellegrino Jr., a Director of Lemaitre Vascular Inc. (LMAT), acquired a total of 20 shares of common stock on December 8, 2025.
  • These shares were acquired at a price of $0 per share.
  • The acquisition resulted from the release of dividend equivalent rights (DERs) on a one-for-one basis.
  • Specifically, 9 shares were acquired from DERs connected to a restricted stock unit (RSU) award granted on December 8, 2023.
  • Another 11 shares were acquired from DERs connected to a performance stock unit (PSU) award granted on December 8, 2023.
  • Following these transactions, Mr. Pellegrino directly beneficially owns 9,589 shares of common stock.

Sentiment

Score: 6

Explanation: The filing reports an expected insider acquisition of shares through the vesting of equity awards, which is a routine event. It slightly increases insider ownership, which is generally a positive signal for alignment of interests, but does not indicate new capital deployment or significant market activity.

Positives

  • Director Joseph P. Pellegrino Jr. increased his direct beneficial ownership in Lemaitre Vascular Inc. by 20 shares, aligning his interests further with shareholders.
  • The acquisition of shares through vesting of equity awards demonstrates the company's commitment to long-term incentive plans for its directors.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

  • The acquisition of shares by Director Joseph P. Pellegrino Jr. through the vesting of equity awards is a transaction between an insider (related party) and the company.

Stakeholder Impact

  • Shareholders: Increased alignment of interests between a director and shareholders due to increased direct ownership.
  • Employees: Reinforces the company's use of equity compensation to incentivize and retain key personnel.

Key Dates

DateDescription
12/08/2023Grant date of restricted stock unit (RSU) and performance stock unit (PSU) awards.
12/08/2025Transaction date for the acquisition of common stock upon release of dividend equivalent rights.
12/10/2025Date the Form 4 was signed by the reporting person's attorney-in-fact.

Recommendation

hold

This Form 4 filing reports a routine, expected acquisition of shares by a director through the vesting of previously granted equity awards. It does not indicate any new strategic developments, operational performance, or significant open market transactions that would warrant a change in investment recommendation. The increased insider ownership is a minor positive for alignment but does not fundamentally alter the investment thesis for Lemaitre Vascular Inc.

Keywords

Lemaitre Vascular, LMAT, Joseph P. Pellegrino Jr., Director, Insider Transaction, Form 4, Stock Acquisition, Restricted Stock Unit, Performance Stock Unit, Dividend Equivalent Rights, Equity Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.